The research group of Dr. Michael Jantsch from the Max F. Perutz Laboratories,
University of Vienna would be interested in cooperation on the following
topics:
HEALTH-2007-1.1-4: SME-driven collaborative research projects for developing
tools and technologies for high-throughput research
HEALTH-2007-2.2.1-8: From mood disorders to experimental models.
HEALTH-2007-2.4.1-1: Translating the knowledge on non-coding RNAs linked to
the aetiology of cancer into novel diagnosis and therapy strategies.
Michael Jantsch's group aims to develop a method or screen to evaluate the
effect of RNA editing on micro RNAs and coding RNA targets with special
emphasis to disease related processes (chronic depression, tumor development)
Please find the profile attached and in the Xtranet at:
http://www.smesgolifesciences.be/xtranet/var/SGLProfilesDetails.asp?ID=1213
Profile #1213
Profile #1213 - Max F. Perutz Laboratories, University of Vienna - Austria
Date: 2007/02/12
Deadline: 2013/03/31
Contact
Organisation
Max F. Perutz Laboratories, University
of Vienna
Contact person
Jantsch, Dr. Michael
Email
Michael.Jantsch@univie.ac.at
Address
Dr. Bohr Gasse 1
Postcode
1030
Country
Austria
Telephone
+43-1-4277 56230
Website
http://www.mfpl.ac.at/index.php?cid=70
Department
Chromosome Biology
City
Vienna
Fax
+43-1-4277 9562
Organisation
Type:
Research Organisation & Universities
Is a Small and Medium Sized Enterprise (SME)? NO
Number of Employees
1000
Description of research activity:
Basic research in cellular and molecular biology
Former participation in an FP European project? NO
Research topics
• HEALTH-2007-1.1-4: SME-driven collaborative research projects for developing tools and technologies for high-throughput
research
• HEALTH-2007-2.2.1-8: From mood disorders to experimental models.
• HEALTH-2007-2.4.1-1: Translating the knowledge on non-coding RNAs linked to the aetiology of cancer into novel diagnosis and
therapy strategies.
Expertise/commitment offered
Keywords specifying
the expertise:
RNA editing, RNA transport, RNA maturation, cell biology
Description of the
expertise:
Modulation of RNA sequences due to adenosine deamination.
Yeast screens to identify modulators of editing activity
Splicing assays
Serotonin receptor editing
Commitment offered
Research,Training
Expectations
Term commitment:
Medium (1 to 3 years)
Expected results for
your organisation:
Develop a method or screen to evaluate the effect of RNA editing on micro RNAs and coding RNA
targets with special emphasis to disease related processes (chronic depression, tumor development)